Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

CLB Core Laboratories N V

Price (delayed)

$11.09

Market cap

$519.93M

P/E Ratio

17.89

Dividend/share

$0.04

EPS

$0.62

Enterprise value

$677.83M

Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 ...

Highlights
The stock's price to earnings (P/E) is 62% less than its 5-year quarterly average of 47.4 and 41% less than its last 4 quarters average of 30.1
CLB's debt is down by 15% YoY
CLB's net income is down by 25% year-on-year and by 11% since the previous quarter
Core Laboratories N V's EPS has decreased by 23% YoY and by 10% from the previous quarter

Key stats

What are the main financial stats of CLB
Market
Shares outstanding
46.88M
Market cap
$519.93M
Enterprise value
$677.83M
Valuations
Price to earnings (P/E)
17.89
Price to book (P/B)
2.05
Price to sales (P/S)
1
EV/EBIT
12.62
EV/EBITDA
9.89
EV/Sales
1.31
Earnings
Revenue
$517.8M
Gross profit
$102.39M
Operating income
$54.4M
Net income
$28.03M
EBIT
$53.7M
EBITDA
$68.52M
Free cash flow
$46.36M
Per share
EPS
$0.62
EPS diluted
$0.6
Free cash flow per share
$0.99
Book value per share
$5.41
Revenue per share
$11.07
TBVPS
$10.39
Balance sheet
Total assets
$591.52M
Total liabilities
$332.16M
Debt
$180M
Equity
$253.39M
Working capital
$125.04M
Liquidity
Debt to equity
0.71
Current ratio
2.21
Quick ratio
1.34
Net debt/EBITDA
2.3
Margins
EBITDA margin
13.2%
Gross margin
19.8%
Net margin
5.4%
Operating margin
10.5%
Efficiency
Return on assets
4.7%
Return on equity
11.3%
Return on invested capital
9.6%
Return on capital employed
11%
Return on sales
10.4%
Dividend
Dividend yield
0.36%
DPS
$0.04
Payout ratio
6.5%

CLB stock price

How has the Core Laboratories N V stock price performed over time
Intraday
-3.31%
1 week
2.59%
1 month
-10.13%
1 year
-38.04%
YTD
-35.93%
QTD
-26.02%

Financial performance

How have Core Laboratories N V's revenue and profit performed over time
Revenue
$517.8M
Gross profit
$102.39M
Operating income
$54.4M
Net income
$28.03M
Gross margin
19.8%
Net margin
5.4%
CLB's net margin is down by 26% YoY and by 10% from the previous quarter
CLB's net income is down by 25% year-on-year and by 11% since the previous quarter
Core Laboratories N V's operating income has decreased by 7% QoQ and by 4.1% YoY
The operating margin has decreased by 6% from the previous quarter and by 5% YoY

Price vs fundamentals

How does CLB's price correlate with its fundamentals

Growth

What is Core Laboratories N V's growth rate over time

Valuation

What is Core Laboratories N V stock price valuation
P/E
17.89
P/B
2.05
P/S
1
EV/EBIT
12.62
EV/EBITDA
9.89
EV/Sales
1.31
The stock's price to earnings (P/E) is 62% less than its 5-year quarterly average of 47.4 and 41% less than its last 4 quarters average of 30.1
Core Laboratories N V's EPS has decreased by 23% YoY and by 10% from the previous quarter
The P/B is 70% below the 5-year quarterly average of 6.8 and 40% below the last 4 quarters average of 3.4
CLB's equity is up by 9% YoY
CLB's price to sales (P/S) is 52% lower than its 5-year quarterly average of 2.1 and 38% lower than its last 4 quarters average of 1.6

Efficiency

How efficient is Core Laboratories N V business performance
The return on equity has declined by 32% year-on-year and by 12% since the previous quarter
The ROA has contracted by 25% YoY and by 11% from the previous quarter
Core Laboratories N V's ROS has decreased by 5% from the previous quarter and by 5% YoY
The return on invested capital has declined by 5% since the previous quarter but it is up by 3.2% year-on-year

Dividends

What is CLB's dividend history
DPS
$0.04
Dividend yield
0.36%
Payout ratio
6.5%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Core Laboratories N V financials performed over time
The total assets is 78% greater than the total liabilities
CLB's current ratio is down by 18% year-on-year and by 4.7% since the previous quarter
The quick ratio has decreased by 12% YoY
CLB's debt is 29% less than its equity
The debt to equity has decreased by 22% YoY
CLB's debt is down by 15% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.